Creative Planning’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-5,858
Closed -$230K – 3096
2023
Q2
$230K Buy
+5,858
New +$207K ﹤0.01% 2108
2022
Q3
– Sell
-28,790
Closed -$277K – 2480
2022
Q2
$277K Buy
28,790
+160
+0.6% +$2.01K ﹤0.01% 1668
2022
Q1
$482K Hold
28,630
– – ﹤0.01% 1336
2021
Q4
$479K Hold
28,630
– – ﹤0.01% 1328
2021
Q3
$465K Sell
28,630
-25,645
-47% -$279K ﹤0.01% 1347
2021
Q2
$342K Sell
54,275
-646
-1% -$4.17K ﹤0.01% 1496
2021
Q1
$339K Hold
54,921
– – ﹤0.01% 1719
2020
Q4
$380K Hold
54,921
– – ﹤0.01% 1470
2020
Q3
$310K Hold
54,921
– – ﹤0.01% 1405
2020
Q2
$280K Hold
54,921
– – ﹤0.01% 1354
2020
Q1
$189K Hold
54,921
– – ﹤0.01% 1406
2019
Q4
$471K Hold
54,921
– – ﹤0.01% 1143
2019
Q3
$62K Hold
54,921
– – ﹤0.01% 1770
2019
Q2
$71K Hold
54,921
– – ﹤0.01% 1781
2019
Q1
$77K Buy
54,921
+646
+1% +$903 ﹤0.01% 1741
2018
Q4
$65K Hold
54,275
– – ﹤0.01% 1683
2018
Q3
$128K Hold
54,275
– – ﹤0.01% 1753
2018
Q2
$148K Hold
54,275
– – ﹤0.01% 1697
2018
Q1
$149K Buy
54,275
+1,200
+2% +$3.48K ﹤0.01% 1679
2017
Q4
$166K Hold
53,075
– – ﹤0.01% 1656
2017
Q3
$150K Buy
53,075
+6,134
+13% +$16.6K ﹤0.01% 1662
2017
Q2
$120K Buy
46,941
+45,996
+4,867% +$125K ﹤0.01% 1859
2017
Q1
$3K Buy
945
+645
+215% +$2.73K ﹤0.01% 4200
2016
Q4
$1K Sell
300
-5,000
-94% -$148K ﹤0.01% 4526
2016
Q3
$244K Sell
5,300
-227
-4% -$12.8K ﹤0.01% 1295
2016
Q2
$282K Buy
5,527
+2,100
+61% +$104K ﹤0.01% 1085
2016
Q1
$145K Buy
+3,427
New +$175K ﹤0.01% 1399

Creative Planning's ISEE Position: Q3 2023 in Review

Creative Planning sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 5,858 shares — an estimated $230K sold.

Creative Planning first reported a position in ISEE in Q1 2016 and held it in 27 quarters. The position peaked at $482K in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Creative Planning reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Creative Planning sold 5,858 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $230K.
  • Creative Planning first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 27 quarters.
  • Creative Planning's IVERIC bio, Inc. Common Stock position peaked at $482K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Creative Planning's 13F filing for Q3 2023, filed 16 Nov 2023.